AIP
THRD

Ameritas Investment Partners’s Third Harmonic Bio THRD Stock Holding History

Ameritas Investment Partners’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,017
Closed -$61 – 3177
2025
Q3 		$61 Hold
2,017
– – ﹤0.01% 3139
2025
Q2 		$11K Hold
2,017
– – ﹤0.01% 2951
2025
Q1 		$7K Hold
2,017
– – ﹤0.01% 2907
2024
Q4 		$20.8K Hold
2,017
– – ﹤0.01% 2618
2024
Q3 		$27.3K Hold
2,017
– – ﹤0.01% 2500
2024
Q2 		$26.2K Hold
2,017
– – ﹤0.01% 2498
2024
Q1 		$19K Hold
2,017
– – ﹤0.01% 2581
2023
Q4 		$22.1K Buy
2,017
+1,007
+100% +$7.98K ﹤0.01% 2545
2023
Q3 		$6.45K Hold
1,010
– – ﹤0.01% 2943
2023
Q2 		$4.86K Hold
1,010
– – ﹤0.01% 3032
2023
Q1 		$4.16K Hold
1,010
– – ﹤0.01% 2894
2022
Q4 		$4.32K Buy
+1,010
New +$16.9K ﹤0.01% 2943

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Ameritas Investment Partners's THRD Position: Q4 2025 in Review

Ameritas Investment Partners sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 2,017 shares — an estimated $61 sold.

Ameritas Investment Partners first reported a position in THRD in Q4 2022 and held it in 12 quarters. The position peaked at $27.3K in Q3 2024. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Ameritas Investment Partners reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,017 Third Harmonic Bio shares in Q4 2025, an estimated $61.
  • Ameritas Investment Partners first reported a position in Third Harmonic Bio in Q4 2022 and held it in 12 quarters.
  • Ameritas Investment Partners's Third Harmonic Bio position peaked at $27.3K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.